EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy

Akinori Yamaguchi, Atsuyoshi Mita, Kosuke Sonoda, Makoto Harada, Koji Hashimoto, Hiroshi Imamura, Yuji Kamijo

Therapeutic Apheresis and Dialysis · 2026-08 · 30 (4) · 460-470

DOI: 10.1002/1744-9987.70165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 07.06.2026. Verfasst von Akinori Yamaguchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Acute Kidney Injury, Sodium, Renal Replacement Therapy. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients requiring long‐term continuous renal replacement therapy (CRRT) generally have poor prognoses. This study evaluated whether adding continuous intravenous sodium infusion (cIVNa) is associated with improved hemodynamics and outcomes in patients undergoing long‐term CRRT for ≥ 7 days.

Methods

This secondary analysis included 46 patients with acute kidney injury who required ≥ 7 days of CRRT from a previously published cohort. Patients received either conventional CRRT ( n = 24) or CRRT plus cIVNa ( n = 22). Hemodynamic parameters, fluid balance, laboratory findings, and clinical outcomes were compared. Results cIVNa group exhibited more stable hemodynamics, higher urine output, and a more favorable fluid balance. Rates of 90‐day survival without renal replacement therapy (RRT) (42.9% vs. 12.5%, p < 0.05), survival to ICU discharge (68.2% vs. 29.2%, p < 0.05), and CRRT/RRT withdrawal were significantly higher among patients receiving cIVNa than among those receiving conventional CRRT. Conclusion cIVNa may support hemodynamic stability and improve RRT withdrawal and survival outcomes in patients requiring long‐term CRRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Renal Replacement TherapyAcute Kidney InjurySodiumRenal Replacement TherapyHumansInfusions, IntravenousPrognosisFemaleMaleAgedHemodynamicsMiddle AgedRetrospective StudiesTime FactorsSurvival Rate

Stichwörter der Autor:innen

acute kidney injurycontinuous intravenous sodium infusioncontinuous renal replacement therapyhigh‐sodium dialysatemultimodal approach

Substanzen

Sodium

Autor:innen und Institutionen

  • Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
  • Intensive Care Unit, Shinshu University Hospital, Matsumoto, Nagano, Japan.

Zitieren

APA

Yamaguchi, A., Mita, A., Sonoda, K., Harada, M., Hashimoto, K., Imamura, H., & Kamijo, Y. (2026). Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy. Therapeutic Apheresis and Dialysis, 30(4), 460-470. https://doi.org/10.1002/1744-9987.70165

Vancouver

Yamaguchi A, Mita A, Sonoda K, Harada M, Hashimoto K, Imamura H, et al. Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy. Therapeutic Apheresis and Dialysis. 2026;30(4):460-470. doi:10.1002/1744-9987.70165

BibTeX
@article{Yamaguchi2026,
  author = {Yamaguchi, Akinori and Mita, Atsuyoshi and Sonoda, Kosuke and Harada, Makoto and Hashimoto, Koji and Imamura, Hiroshi and Kamijo, Yuji},
  title = {Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {4},
  pages = {460--470},
  doi = {10.1002/1744-9987.70165}
}
Kostenlos starten →